HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
CJC-1295 with DACHPLC ≥ 98%MS confirmed2mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | CJC-1295 with DAC |
|---|---|
| CAS number | 446262-90-4 |
| Class | Growth-hormone axis & repair |
| Molecular formula | C165H269N47O46 |
| Molecular weight | 3647.2 g/mol |
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(ε-maleimidopropionyl)-NH2 |
| Form | Lyophilized powder, sterile glass vial |
| Purity target | ≥ 98% by HPLC |
| Vial formats | 2mg / 5mg |
| Documentation | COA + HPLC + MS, batch lot file where available |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C, protected from light and moisture; short-term handling at 2-8°C is acceptable. After reconstitution, keep at 2-8°C and use within a limited window; avoid repeated freeze-thaw. Ships with cold-chain / ice-pack packaging. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 50 vials | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
CJC-1295 with DAC is a long-acting GHRH(1-29) analog carrying a maleimidopropionyl Drug Affinity Complex that covalently binds serum albumin to extend circulating half-life, supplied by Pepti as a research-use lyophilized peptide for B2B and private-label buyers.
Documentation
Batch documentation support for CJC-1295 with DAC lots.
COA / HPLC / MS document support where available. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the CJC-1295 with DAC reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
CJC-1295 with DAC — frequently asked by B2B buyers.
What vial sizes and MOQ does Pepti offer for CJC-1295 with DAC?
We supply CJC-1295 with DAC as a lyophilized research-use powder in 2 mg and 5 mg vials, with a minimum order quantity of 50 vials. Larger bulk quantities and custom fill weights are available on RFQ.
How is purity and identity documented?
Each lot ships with a Certificate of Analysis reporting HPLC purity (typically >98%) and identity confirmation by mass spectrometry. Batch-specific COA, and where required the underlying HPLC/MS chromatograms, are provided on request.
How does CJC-1295 with DAC differ from CJC-1295 without DAC (Mod GRF 1-29)?
Both share the same [D-Ala2, Gln8, Ala15, Leu27] GHRH(1-29) backbone, but the DAC version adds a C-terminal lysine bearing a maleimidopropionyl group that covalently binds serum albumin in research models, substantially extending circulating half-life. The non-DAC variant lacks this albumin-binding moiety and clears far more rapidly.
What private-label and OEM options are available?
Pepti provides custom vial labeling, kit configuration, and documentation packages for private-label brands and distributors. Reconstitution ancillaries such as bacteriostatic water can be bundled into finished kits on request.
What are the compliance and intended-use restrictions?
CJC-1295 with DAC is supplied strictly for laboratory and research use, not for human or veterinary consumption. Buyers are responsible for meeting import, licensing, and regulatory requirements in their destination market.
Related compounds